Schedule 13D ownership disclosure
Monopar Therapeutics Inc
Security class unavailable · CUSIP: 61023L207
Event date: 2024-12-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 16.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001437749-24-037745
- Form type
- SC 13D
- Filer
- Monopar Therapeutics
- CIK
- CIK 1645469
- Filed
- Dec 17, 2024
- Reporting period
- Dec 09, 2024
- Description
- Schedule 13D beneficial ownership